AU2294192A - Transdermal nicotine absorption dosage unit and process - Google Patents

Transdermal nicotine absorption dosage unit and process

Info

Publication number
AU2294192A
AU2294192A AU22941/92A AU2294192A AU2294192A AU 2294192 A AU2294192 A AU 2294192A AU 22941/92 A AU22941/92 A AU 22941/92A AU 2294192 A AU2294192 A AU 2294192A AU 2294192 A AU2294192 A AU 2294192A
Authority
AU
Australia
Prior art keywords
dosage unit
transdermal nicotine
nicotine absorption
absorption dosage
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22941/92A
Inventor
Chin-Chih Chiang
Jhili Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TBS Laboratories Inc
Original Assignee
TBS Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TBS Laboratories Inc filed Critical TBS Laboratories Inc
Publication of AU2294192A publication Critical patent/AU2294192A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
AU22941/92A 1991-06-26 1992-06-24 Transdermal nicotine absorption dosage unit and process Abandoned AU2294192A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72112991A 1991-06-26 1991-06-26
US721129 1991-06-26

Publications (1)

Publication Number Publication Date
AU2294192A true AU2294192A (en) 1993-01-25

Family

ID=24896654

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22941/92A Abandoned AU2294192A (en) 1991-06-26 1992-06-24 Transdermal nicotine absorption dosage unit and process

Country Status (6)

Country Link
EP (1) EP0544900A4 (en)
CN (1) CN1067811A (en)
AU (1) AU2294192A (en)
CA (1) CA2094913A1 (en)
TW (1) TW221970B (en)
WO (1) WO1993000057A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09505028A (en) * 1993-07-09 1997-05-20 シグナス，インコーポレイテッド Methods and devices for providing percutaneous / buccal nicotine replacement therapy
JP5000932B2 (en) * 2005-06-21 2012-08-15 日東電工株式会社 Nicotine-containing transdermal preparation
ES2499067T3 (en) 2005-10-13 2014-09-26 Nitto Denko Corporation Transdermal preparation of nicotine and its production method
EP2377540A1 (en) * 2010-03-31 2011-10-19 Hexal AG Transdermal patch containing 17-deacetyl norgestimate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
CH672888A5 (en) * 1986-11-07 1990-01-15 Mepha Ag
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
DE4020144A1 (en) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Patches for topical or transdermal drug delivery - with adhesive layer contg. polyacrylate adhesive and film former

Also Published As

Publication number Publication date
CA2094913A1 (en) 1992-12-27
EP0544900A4 (en) 1993-12-01
CN1067811A (en) 1993-01-13
WO1993000057A1 (en) 1993-01-07
EP0544900A1 (en) 1993-06-09
TW221970B (en) 1994-04-01

Similar Documents

Publication Publication Date Title
AU6480994A (en) Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
GB2276639B (en) Solutions for wood treatment and their preparation
AU7237394A (en) Morphinan derivative and medicinal use
AU664362B2 (en) Absorbent pads and process therefor
AU5106890A (en) Device for the transdermal delivery of nicotine
AU7323794A (en) Method and device for providing nicotine replacement therapy transdermally/transbuccally
AU2187992A (en) Composition and method for disease treatment
HUT62022A (en) Absorptive materials and process for producing same
SK60895A3 (en) Taxane derivatives and process for their preparation
AU1124292A (en) Cutting apparatus and process
AU623147B2 (en) Compounds for use in medicine
AU1433292A (en) Material treatment apparatus
AU7366791A (en) A method and a pharmaceutical preparation for treating pain
AU2312392A (en) Skin treatment device
GB9120628D0 (en) Pyrrolobenzoxazine derivatives and process for preparation thereof
IL107133A0 (en) Piperidine derivatives,their preparation and their application in therapy
AU1279788A (en) Compounds and treatment
GB9320676D0 (en) Treatment fo wood
AU7793791A (en) Pharmaceutical composition for use in treating pain
AU2294192A (en) Transdermal nicotine absorption dosage unit and process
ZA933899B (en) Thienothiazine derivatives process for their preparation and their use
SG46724A1 (en) Use of granisetron for the treatment of post operative nausea and vomittung
AU3222893A (en) Therapeutic composition and method for preventing reperfusion injury
AU1507992A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapy
ZA928198B (en) Substituted azaspiranes for use in the treatment of hyperlipidemia